New drug tested to help heart failure patients breathe easier
NCT ID NCT06506994
Summary
This early-stage study tested a new injectable drug called HRS-9057 to see if it is safe and can help reduce dangerous fluid buildup in people with heart failure. It compared the new injection to an existing pill (tolvaptan) in 24 patients who still had swelling and congestion despite taking standard water pills. The main goal was to check for side effects while also measuring changes in body fluid levels, weight, and swelling over 8 days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH VOLUME OVERLOAD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, 510285, China
Conditions
Explore the condition pages connected to this study.